Folgen
Alexey Stukalov
Alexey Stukalov
Seer, Inc.
Bestätigte E-Mail-Adresse bei seer.bio
Titel
Zitiert von
Zitiert von
Jahr
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network Tissue source sites: Duke University ...
Nature 455 (7216), 1061-1068, 2008
73232008
Gene essentiality and synthetic lethality in haploid human cells
VA Blomen, P Májek, LT Jae, JW Bigenzahn, J Nieuwenhuis, J Staring, ...
Science 350 (6264), 1092-1096, 2015
8602015
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
A Stukalov, V Girault, V Grass, O Karayel, V Bergant, C Urban, DA Haas, ...
Nature 594 (7862), 246-252, 2021
5852021
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy
KVM Huber, E Salah, B Radic, M Gridling, JM Elkins, A Stukalov, ...
Nature 508 (7495), 222-227, 2014
4372014
Artemisinins target GABAA receptor signaling and impair α cell identity
J Li, T Casteels, T Frogne, C Ingvorsen, C Honore, M Courtney, ...
Cell 168 (1), 86-100. e15, 2017
3822017
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia
F Grebien, M Vedadi, M Getlik, R Giambruno, A Grover, R Avellino, ...
Nature chemical biology 11 (8), 571-578, 2015
2792015
Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS
M Varjosalo, R Sacco, A Stukalov, A Van Drogen, M Planyavsky, S Hauri, ...
Nature methods 10 (4), 307-314, 2013
2292013
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
A Fauster, M Rebsamen, KVM Huber, JW Bigenzahn, A Stukalov, ...
Cell death & disease 6 (5), e1767-e1767, 2015
1932015
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
S Sadegh, J Matschinske, DB Blumenthal, G Galindez, T Kacprowski, ...
Nature communications 11 (1), 3518, 2020
1652020
Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action
MV Babak, SM Meier, KVM Huber, J Reynisson, AA Legin, MA Jakupec, ...
Chemical science 6 (4), 2449-2456, 2015
1532015
An orthogonal proteomic survey uncovers novel Zika virus host factors
P Scaturro, A Stukalov, DA Haas, M Cortese, K Draganova, A Płaszczyca, ...
Nature 561 (7722), 253-257, 2018
1502018
A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape
P Hubel, C Urban, V Bergant, WM Schneider, B Knauer, A Stukalov, ...
Nature immunology 20 (4), 493-502, 2019
1482019
Functional dissection of the TBK1 molecular network
A Goncalves, T Bürckstümmer, E Dixit, R Scheicher, MW Gorna, E Karayel, ...
PloS one 6 (9), e23971, 2011
1342011
Imprinted Igf2r silencing depends on continuous Airn lncRNA expression and is not restricted to a developmental window
F Santoro, D Mayer, RM Klement, KE Warczok, A Stukalov, DP Barlow, ...
Development 140 (6), 1184-1195, 2013
1012013
Clinical significance of genetic aberrations in secondary acute myeloid leukemia
JD Milosevic, A Puda, L Malcovati, T Berg, M Hofbauer, A Stukalov, ...
American journal of hematology 87 (11), 1010-1016, 2012
1002012
Germline RBBP6 mutations in familial myeloproliferative neoplasms
AS Harutyunyan, R Giambruno, C Krendl, A Stukalov, T Klampfl, T Berg, ...
Blood, The Journal of the American Society of Hematology 127 (3), 362-365, 2016
632016
The RNA‐binding protein HuR/ELAVL1 regulates IFN‐β mRNA abundance and the type I IFN response
B Herdy, T Karonitsch, GI Vladimer, CSH Tan, A Stukalov, C Trefzer, ...
European journal of immunology 45 (5), 1500-1511, 2015
572015
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms
J Li, K Bennett, A Stukalov, B Fang, G Zhang, T Yoshida, I Okamoto, ...
Molecular systems biology 9 (1), 705, 2013
532013
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
A Skucha, J Ebner, J Schmöllerl, M Roth, T Eder, A César-Razquin, ...
Nature Communications 9 (1), 1983, 2018
512018
Blackboxoptim. jl
R Feldt, A Stukalov
See https://github. com/robertfeldt/BlackBoxOptim. jl, 2018
482018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20